Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients

Journal of Clinical Psychopharmacology

Volumn 26, Issue 3, 2006, Pages 274-283

  Lintzeris, Nicholas ^a,b,c   Mitchell, Timothy B ^a   Bond, Alyson ^a   Nestor, Liam ^a   Strang, John ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; DIAMORPHINE; DIAZEPAM; METHADONE; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; BREATHING RATE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; METHADONE TREATMENT; OXYGEN TENSION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; PULSE RATE; PUPIL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SEDATION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; BUPRENORPHINE; DIAZEPAM; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HEROIN DEPENDENCE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; METHADONE; NARCOTICS; OXYGEN CONSUMPTION; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 33744484528     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000219050.33008.61     Document Type: Article

References (33)

1. Stitzer M, Griffiths R, McLellan A, et al. Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend. 1981;8(3):189-199.
2. Gossop M, Marsden J, Stewart D, et al. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction. 2003;98(3):291-303.
3. Darke S. Benzodiazepine use among injecting drug users: problems and implications. Addiction. 1994;89(4):379-382.
4. Kandel D, Huang FY, Davies M. Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend. 2001;64(2):233-241.
5. Marsden J, Gossop M, Stewart D, et al. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry. 2000;176:285-289.
6. Farrell M, Howe S, Taylor C, et al. Substance misuse and psychiatric comorbidity: an overview of the OPCS national psychiatric morbidity survey. Addictive Behaviours. 1998;23:909-918.
7. Ernst E, Bartu A, Popescu A, et al. Methadone-related deaths in Western Australia 1993-99. Aust N Z J Public Health. 2002;26(4):364-370.
8. Wolf B, Lavezzi W, Sullivan L, et al. Methadone-related deaths in Palm Beach County. J Forensic Sci. 2004;49(2):375-378.
9. Zador D, Sunjic S. Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995. Addiction. 2000;95(1):77-84.
10. Pirnay S, Borron S, Giudicelli C, et al. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction. 2004;99(8):978-988.
11. Grass H, Behnsen S, Kimont H, et al. Methadone and its role in drug-related fatalities in Cologne 1989-2000. Forensic Sci Int. 2003;132(3):195-200.
12. Preston K, Griffiths R, Stitzer M, et al. Diazepam and methadone interactions in methadone maintenance. Clin Pharmacol Ther. 1984;36(4):534.
13. Farre M, Teran M, Roset P, et al. Abuse liability of flunitrazepam among methadone-maintained patients. Psychopharmacology. 1998;140:486-495.
14. Walsh SL, Preston KL, Stitzer ML, et al. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther. 1994;55(5):569-580.
15. Kay B. Buprenorphine, benzodiazepines and respiratory depression. Anaesthesia. 1984;39:491-492.
16. Faroqui MH, Cole M, Curran J. Buprenorphine, benzodiazepines and respiratory depression [letter]. Anaesthesia. 1983;38(10):1002-1003.
17. Green DW. Buprenorphine, benzodiazepines and respiratory depression [letter]. Anaesthesia. 1984;39(3):287-288.
18. Sekar M, Mimpriss TJ. Buprenorphine, benzodiazepines and prolonged respiratory depression [letter]. Anaesthesia. 1987;42(5):567-568.
19. Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci Int. 2001;121(1-2):65-69.
20. Gueye P, Borron S, Risede P, et al. Buprenorphine and midazolam act in combination to depress respiration in rats. Toxicol Sci. 2002;65(1):107-114.
21. Borron S, Monier C, Risede P, et al. Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat. Hum Exp Toxicol. 2002;21(11):599-605.
22. Ibrahim R, Wilson J, Thorsby M, et al. Effect of buprenorphine on CYP3A activity in rat and human liver microsomes. Life Sciences. 2000;66(14):1293- 1298.
23. Kilicarslan T, Sellers EM. Lack of interaction of buprenorphine with flunitrazepam metabolism. Am J Psychiatry. 2000;157(7):1164-1166.
24. Pond S, Tong T, Benowitz N, et al. Lack of effect of diazepam on methadone metabolism in methadone-maintained addicts. Clin Pharmacol Ther. 1982;31(2):139-143.
25. Preston K, Griffiths R, Cone E, et al. Diazepam and methadone blood levels following concurrent administration of diazepam and methadone. Drug Alcohol Depend. 1986;18(2):195-202.
26. Mattick R, Kimber J, Breen C, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. [Cochrane Database Syst Rev. (3):CD002207.
27. Martin W, Sloan J, Sapira J, Jasinski D. Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics. 1971;12:245-258.
28. Bond A, James D, Lader M. Physiological and psychological measures in anxious patients. Psychological Medicine. 1974;4:364-373.
29. Wechsler D. Manual for the Wechsler Adult Intelligence Scale. New York: Psychological Corporation, 1955.
30. Evans S, Critchfield T, Griffiths R. Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore. British J Addiction. 1991;86:1625-1632.
31. Curran H. Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biological Psychology. 1986;23:179-213.
32. Handelsman L, Cochrane KJ, Aronson MJ, et al. Two new rating scales for opiate withdrawal. American Journal of Drug and Alcohol Abuse. 1987;13(3):293-308.
33. Curran H, Kleckham J, Bearn J, et al. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology. 2001;154:153-160.